SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events
Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes
Don't Miss a Beat: EMPACT-MI at ACC.24, with Javed Butler, MD
ACC.24 Clinical Trials Recap, with Deepak Bhatt, MD, MPH, MBA
Experts' Perspectives: Advancements in Cardiomyopathy at ACC.24